Abstract
Cancer results from subversion of the processes that control the normal growth, location and mortality of cells. This loss of normal control mechanisms arises from the acquisition of mutations in three broad categories of genes proto-oncogenes, tumor suppressor genes and DNA repair enzymes. Proto-oncogene activation may occur by mutation, gene amplification or DNA rearrangement. Chromosomal translocations entail the generation of gene fusions in both haematopoietic and solid mesenquimal tumors. Despite the successful identification of these specific and consistent genetic events, the nature of the intimate association between the gene fusion and the resulting phenotype is pending to understand. The application of transgenic methods to the study of these cancer-associated gene fusions have provided insights into their in vivo functions and suggested mechanisms by which lineage selection may be achieved. Herein these studies are reviewed to illustrate how manipulation of their loci in the mouse has co ntributed to current understanding in unique and unexpected ways.
Keywords: Translocation-Associated Genes, Proto oncogenes, Tumor suppressor genes, DNA repair Enzymes, Chromosomal translocations, Oncogenes, Human Cancer, DNA rearrangement, Gene amplification, Lineage
Current Genomics
Title: Chromosomal Abnormalities, Cancer and Mouse Models The Critical Role of Translocation-Associated Genes in Human Cancer
Volume: 1 Issue: 1
Author(s): I. Sanchez-Garcia
Affiliation:
Keywords: Translocation-Associated Genes, Proto oncogenes, Tumor suppressor genes, DNA repair Enzymes, Chromosomal translocations, Oncogenes, Human Cancer, DNA rearrangement, Gene amplification, Lineage
Abstract: Cancer results from subversion of the processes that control the normal growth, location and mortality of cells. This loss of normal control mechanisms arises from the acquisition of mutations in three broad categories of genes proto-oncogenes, tumor suppressor genes and DNA repair enzymes. Proto-oncogene activation may occur by mutation, gene amplification or DNA rearrangement. Chromosomal translocations entail the generation of gene fusions in both haematopoietic and solid mesenquimal tumors. Despite the successful identification of these specific and consistent genetic events, the nature of the intimate association between the gene fusion and the resulting phenotype is pending to understand. The application of transgenic methods to the study of these cancer-associated gene fusions have provided insights into their in vivo functions and suggested mechanisms by which lineage selection may be achieved. Herein these studies are reviewed to illustrate how manipulation of their loci in the mouse has co ntributed to current understanding in unique and unexpected ways.
Export Options
About this article
Cite this article as:
Sanchez-Garcia I., Chromosomal Abnormalities, Cancer and Mouse Models The Critical Role of Translocation-Associated Genes in Human Cancer, Current Genomics 2000; 1 (1) . https://dx.doi.org/10.2174/1389202003351814
DOI https://dx.doi.org/10.2174/1389202003351814 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
PI3K/Akt Signalling Pathway Specific Inhibitors: A Novel Strategy to Sensitize Cancer Cells to Anti-Cancer Drugs
Current Pharmaceutical Design Chemical Metabolic Inhibitors for the Treatment of Blood-Borne Cancers
Anti-Cancer Agents in Medicinal Chemistry Can γH2AX be Used to Personalise Cancer Treatment?
Current Molecular Medicine Antibodies for Therapeutic Uses and the Evolution of Biotechniques
Current Medicinal Chemistry HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Metastatic Cancer Stem Cells: New Molecular Targets for Cancer Therapy
Current Pharmaceutical Biotechnology Recent Advances in the Synthesis and Anticancer Activity of Some Molecules Other Than Nitrogen Containing Heterocyclic Moeities
Mini-Reviews in Medicinal Chemistry Glutaminase Isoenzymes as Key Regulators in Metabolic and Oxidative Stress Against Cancer
Current Molecular Medicine Laccases in Pharmaceutical Chemistry: A Comprehensive Appraisal
Mini-Reviews in Organic Chemistry The Role of Glycogen Synthase Kinase-3β in Normal Haematopoiesis, Angiogenesis and Leukaemia
Current Medicinal Chemistry Safety and Utilization of Blood Components as Therapeutic Delivery Systems
Current Pharmaceutical Biotechnology Small-Molecule Inhibitors Targeting eIF4A in Leukemia
Current Protein & Peptide Science Cyclin Dependent Kinase 1 Inhibitors: A Review of Recent Progress
Current Medicinal Chemistry Antibody Engineering, Virus Retargeting and Cellular Immunotherapy: One Ring to Rule Them All?
Current Gene Therapy Modulation of Energy Intake and Expenditure Due to Habitual Physical Exercise
Current Pharmaceutical Design Uric Acid and Hypertension
Current Pharmaceutical Design Biological Activities of Yarrow Species (Achillea spp.)
Current Pharmaceutical Design Structural and Functional Role of Gly281 in L-asparaginase from Erwinia carotovora
Protein & Peptide Letters Flavonoids in Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry Recent Advances in Biological Strategies for Targeted Drug Delivery
Cardiovascular & Hematological Disorders-Drug Targets